Femme et Homme
- | Pays :
- Italy
- | Organes : -
- | Spécialités : -
Extrait
The patient receive 2 different drug combinations on this study. The first combination will consist of an intensive chemotherapy regimen (cyclophosphamide, mesna, methotrexate, doxorubicin liposomal or doxorubicin, vincristine, ARA-C (cytarabine) and dexamethasone). The second combination will consist of another intensive chemotherapy regimen (methotrexate and Ara-C [cytarabine]).
Critère d'inclusion
- Lymphoid leukemia